Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Novel anti-inflammatory agent significantly improves LPS-induced sepsis in vivo

Oct. 28, 2021

RFN-ALFQ nanoparticle vaccine elicits immunity against SARS-CoV-2 in macaques

Oct. 27, 2021

Thomas Jefferson University, Context Therapeutics patent androgen and SIGMAR1 receptor antagonists

Oct. 26, 2021

Janssen BioPharma presents compounds for inhibiting respiratory syncytial virus replication

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

Monash University divulges antibiotic peptide-drug conjugates

Oct. 25, 2021

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Oct. 22, 2021

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Oct. 21, 2021

EDP-235 demonstrates potent antiviral activity against SARS-CoV-2 in cellular models

Oct. 20, 2021

Debiopharm awarded further funding to target N. gonorrhoeae

Oct. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.